Dividends Calendar Earnings Calendar
BCRX

BCRX | BioCryst Pharmaceuticals Inc

BioCryst Pharmaceuticals Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Durham, North Carolina, United States

Trade prices

  • Volume:
  • Market Cap: 2.01B
  • Prev closed: 8.2
  • Open: 8.12
  • High: 8.61
  • Low: 8.08
  • 52 week low: 1.58
  • 52 week high: 8.99
  • Dividends:No Dividends

Next ER: August 3, 2023 



Top Stories (BCRX)

    About the Company

    BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug RAPIVAB was approved by FDA in Dec 2014.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    November 8, 2023
    August 3, 2023-0.24 / -0.2381M / 81.41M
    May 3, 2023-0.28 / -0.368.4M / 71.47M
    February 21, 2023-0.38 / -0.166479.55M / 75.23MBeat!
    November 2, 2022-0.23 / -0.2975.83M / 74.62MBeat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Jul 28, 2023 7.68 7.65
    7.88
    7.57
    2.0M -0.9%
    Jul 27, 2023 7.75 7.95
    7.95
    7.71
    5.8M -2.15%
    Jul 26, 2023 7.92 7.64
    7.93
    7.59
    2.7M 3.66%
    Jul 25, 2023 7.64 7.34
    7.74
    7.33
    1.8M 3.80%
    Jul 24, 2023 7.36 7.48
    7.56
    7.31
    1.4M -1.47%
    Jul 21, 2023 7.47 7.24
    7.54
    7.22
    1.8M 4.18%
    Jul 20, 2023 7.17 7.36
    7.53
    7.14
    2.1M -2.58%
    Jul 19, 2023 7.36 7.24
    7.47
    7.24
    2.2M 2.65%
    Jul 18, 2023 7.17 7.15
    7.28
    7.1
    1.5M -0.28%
    Jul 17, 2023 7.19 7.13
    7.4
    7.11
    2.9M 0.84%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:1986
    • Employees:110

    News

    News for (BCRX)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  Jon P. Stonehouse
    • CFO :  Thomas R. Staab II

    Talk about BioCryst Pharmaceuticals Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Aug 3, 2023 (Same day)

    sq aapl h apd mur ci yelp dva shak bud bkng dbx 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 44
    HOLD 56
    SELL 0

    Their Official Profiles 

    Wikipedia

    Peers / Similar stocks 

    xlv gild srpt 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Intelligent Investor
    Buy on Amazon

    Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

    The best book on investing ever written.
    -- Warren Buffet